View all year-in-review CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.



Accreditation/ Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.

Resources

PER Pulse™ Recaps highlight key elements of the Year in Review™: Reflecting on Recent Evidence with an Eye to the Future of Lung Cancer Management Online CME Activity.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Genentech.


Year in Review™: Reflecting on Recent Evidence with an Eye to the Future of Lung Cancer Management

Release Date: February 28, 2017
Expiration Date: February 28, 2018
Media: Internet - based

Activity Overview

This online activity features an expert panel discussion of noteworthy lung cancer data reported in 2016. These findings encompass the rapidly developing fields of targeted agents, liquid biopsies, and immunotherapy. The experts in this program also discuss how they have incorporated recent findings in the clinic.

CME Activity Table of Contents

  • Introduction
  • Module 1: EGFR/ALK and Liquid Biopsies
  • Module 2: Other Oncogenic Drivers / Targeted Agents in Small-cell Lung Cancer
  • Module 3: Immunotherapy

Requirements for Successful Completion

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video files/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • If you close the web browser after you complete the activity, the Educational Content link will disappear and you will need to review the activity in its entirety to once again access the Educational Content link.
  • In order to receive a CME certificate, participants must complete the activity.
  • Click on the Request Credits link at the end of the activity. Take the posttest and pass with a score of 70% or higher, complete the evaluation, and then click on Request Credits. Participants may immediately download a CME certificate upon completion of these steps.


Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, and pulmonologists involved in the treatment and management of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals (HCPs) interested in the treatment of lung cancer may also participate.


Educational Objectives

At the conclusion of this activity, participants should be better prepared to:

  1. State the design of clinical trials that have utilized prognostic and predictive markers in the treatment of patients with advanced forms of lung cancer
  2. Discuss key findings from recent clinical trials conducted in the setting of advanced NSCLC
  3. Explain recent efficacy and safety results in the context of evolving treatment paradigms in the field and applicability to clinical practices
  4. Describe planned/ongoing clinical trials intended to address remaining unanswered clinical questions in the field of advanced NSCLC management


Faculty, Staff, and Planners' Disclosures

Chair

Benjamin P. Levy, MD
Assistant Professor, Johns Hopkins Medicine
Clinical Director, Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Hospital
Washington, DC
Disclosure: Consultant: AstraZeneca, Celgene, BMS, Eli Lilly, Genentech, Merck and Pfizer

Faculty

Alexander Drilon, MD
Clinical Director, Developmental Therapeutics Clinic
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY

Disclosure: Honoraria: Ariad, AzstraZeneca, Loxo Oncology, Inc., Igynta, and Blueprint Medicines

Sarah B. Goldberg, MD, MPH
Assistant Professor of Medicine (Medical Oncology)
Yale School of Medicine
New Haven, CT


Disclosure: Grant/Research Support: AstraZeneca
 

The staff of Physicians' Education Resource®, LLC, has no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER® to ensure the fair balance, independence, objectivity, and scientific objectivity in all of our CME activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

CME Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Toll-Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705
info@gotoper.com


Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise




Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
293031
Filter By